Evidence map›Paper›PMID 33190414›Full record

ReviewCytoskeleton (Hoboken, N.J.)2020

Vimentin's side gig: Regulating cellular proteostasis in mammalian systems.

Christopher S Morrow, Darcie L Moore

Open access · greenAbstract readReview
In one paragraph

Review in Cytoskeleton (Hoboken, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Christopher S MorrowDepartment of Neuroscience, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Darcie L MooreDepartment of Neuroscience, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-0854-7655
University of Wisconsin–Madison · US

Funding

Training Program In Molecular AND Cellular PharmacologyT32GM008688 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 1998 to 2020
$6.0M
The mechanisms and functional role of the asymmetric segregation of cellular cargoes in stem cellsDP2NS111818 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI MOORE, DARCIE LEANN · 2018 to 2018
$2.2M
NIGMS NIH HHS T32 GM008688NINDS NIH HHS DP2 NS111818
6 · The paper itself

Abstract

Intermediate filaments (IFs) perform a diverse set of well-known functions including providing structural support for the cell and resistance to mechanical stress, yet recent evidence has revealed unexpected roles for IFs as stress response proteins. Previously, it was shown that the type III IF protein vimentin forms cage-like structures around centrosome-associated proteins destined for degradation, structures referred to as aggresomes, suggesting a role for vimentin in protein turnover. However, vimentin's function at the aggresome has remained largely understudied. In a recent report, vimentin was shown to be dispensable for aggresome formation, but played a critical role in protein turnover at the aggresome through localizing proteostasis-related machineries, such as proteasomes, to the aggresome. Here, we review evidence for vimentin's function in proteostasis and highlight the organismal implications of these findings.

Indexed as

AnimalsHumansIntermediate FilamentsMammalsProteostasisVimentinVimentinaggresomeintermediate filamentproteostasisstress responsevimentin

Identifiers

PMID33190414
PMCPMC8216102
OpenAlexW3105364364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.